Fisher & Paykel Healthcare Corporation Limited (AU:FPH)
ASX:FPH
Total Valuation
Fisher & Paykel Healthcare Corporation Limited has a market cap or net worth of AU$17.91B. The enterprise value is AU$21.59B.
Market CapAU$17.91B
Enterprise ValueAU$21.59B
Share Statistics
Fisher & Paykel Healthcare Corporation Limited has 587,289,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding587,289,000
Owned by Insiders0.17%
Owned by Institutions―
Financial Efficiency
Fisher & Paykel Healthcare Corporation Limited’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 20.72%.
Return on Equity (ROE)0.22
Return on Assets (ROA)0.16
Return on Invested Capital (ROIC)20.72%
Return on Capital Employed (ROCE)0.28
Revenue Per Employee335.20K
Profits Per Employee67.14K
Employee Count6,978
Asset Turnover0.82
Inventory Turnover2.56
Valuation Ratios
The current PE Ratio of Fisher & Paykel Healthcare Corporation Limited is 46.6. Fisher & Paykel Healthcare Corporation Limited’s PEG ratio is 1.32.
PE Ratio46.6
PS Ratio9.38
PB Ratio10.37
Price to Fair Value10.37
Price to FCF44.75
Price to Operating Cash Flow32.90
PEG Ratio1.32
Income Statement
In the last 12 months, Fisher & Paykel Healthcare Corporation Limited had revenue of 2.34B and earned 468.50M in profits. Earnings per share was 0.80.
Revenue2.34B
Gross Profit1.50B
Operating Income667.00M
Pretax Income631.50M
Net Income468.50M
EBITDA825.60M
Earnings Per Share (EPS)0.80
Cash Flow
In the last 12 months, operating cash flow was 663.20M and capital expenditures -172.80M, giving a free cash flow of 490.40M billion.
Operating Cash Flow663.20M
Free Cash Flow490.40M
Free Cash Flow per Share0.84
Dividends & Yields
Fisher & Paykel Healthcare Corporation Limited pays an annual dividend of AU$0.319, resulting in a dividend yield of 1.92%
Dividend Per ShareAU$0.319
Dividend Yield1.92%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.73
52-Week Price Change-8.72%
50-Day Moving Average29.91
200-Day Moving Average31.97
Relative Strength Index (RSI)58.99
Average Volume (3m)485.38K
Important Dates
Fisher & Paykel Healthcare Corporation Limited upcoming earnings date is Dec 2, 2026, After Close (Confirmed).
Last Earnings DateMay 25, 2026
Next Earnings DateDec 2, 2026
Ex-Dividend Date―
Financial Position
Fisher & Paykel Healthcare Corporation Limited as a current ratio of 2.31, with Debt / Equity ratio of 6.91%
Current Ratio2.31
Quick Ratio1.66
Debt to Market Cap<0.01
Net Debt to EBITDA-0.38
Interest Coverage Ratio64.76
Taxes
In the past 12 months, Fisher & Paykel Healthcare Corporation Limited has paid 163.00M in taxes.
Income Tax163.00M
Effective Tax Rate0.26
Enterprise Valuation
Fisher & Paykel Healthcare Corporation Limited EV to EBITDA ratio is 26.20, with an EV/FCF ratio of 44.11.
EV to Sales9.25
EV to EBITDA26.20
EV to Free Cash Flow44.11
EV to Operating Cash Flow32.62
Balance Sheet
Fisher & Paykel Healthcare Corporation Limited has AU$461.10M in cash and marketable securities with AU$146.10M in debt, giving a net cash position of AU$315.00M billion.
Cash & Marketable SecuritiesAU$461.10M
Total DebtAU$146.10M
Net CashAU$315.00M
Net Cash Per ShareAU$0.54
Tangible Book Value Per ShareAU$3.48
Margins
Gross margin is 64.16%, with operating margin of 28.52%, and net profit margin of 20.03%.
Gross Margin64.16%
Operating Margin28.52%
Pretax Margin27.00%
Net Profit Margin20.03%
EBITDA Margin35.30%
EBIT Margin28.52%
Analyst Forecast
The average price target for Fisher & Paykel Healthcare Corporation Limited is AU$35.13, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$35.13
Price Target Upside12.48% Upside
Analyst ConsensusModerate Buy
Analyst Count9
Revenue Growth Forecast12.66%
EPS Growth Forecast20.75%